OXT and retinal disorder: Of them, the topical application of CL-717 as eye drops is clinically the most appealing as it raises the possibility of treating proliferative retinopathies, including DR, without intraocular injections of OXT-328 or Q-922 injected either intraocularly or intraperitoneally.